Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Melanoma 2 Malignant Solid Neoplasm 2 Hematopoietic and Lymphatic System Neoplasm 2 Hematologic Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 COVID-19 2 Urologic Neoplasms 1 Urologic Diseases 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Teratoma 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Spondylitis, Ankylosing 1 Renal Insufficiency, Chronic 1 Psoriasis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peritoneal Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Mouth Neoplasms 1

Interventions

Paclitaxel 3 Carboplatin 2 Bevacizumab 2 sodium thiosulfate 1 pembrolizumab 1 olaparib 1 liposomal doxorubicin 1 Topotecan 1 Standard of Care 1 Specimen Handling 1 Saline Solution 1 Practice Guidelines as Topic 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Laparoscopy 1 Glucose 1 Gemcitabine 1 Docetaxel 1 Cytoreduction Surgical Procedures 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Neoplasms × Practice Guidelines as Topic × 30 days × Clear all

NCT07001748 2026-05-15

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡